Carlisle Companies Incorporated (CSL)

Net profit margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income US$ in thousands 767,400 924,000 421,700 320,100 472,800
Revenue US$ in thousands 4,586,900 5,449,400 4,810,300 3,969,900 4,484,600
Net profit margin 16.73% 16.96% 8.77% 8.06% 10.54%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $767,400K ÷ $4,586,900K
= 16.73%

The net profit margin of Carlisle Companies Inc. has exhibited a generally positive trend over the past five years, indicating an improvement in the company's profitability. From 2019 to 2020, there was a slight decrease in net profit margin, which rebounded and steadily increased in subsequent years. The most significant improvement was observed in 2021, where the net profit margin jumped to 8.77% from 7.51% in 2020. This was followed by a substantial increase to 14.02% in 2022 and further growth to 16.73% in 2023.

The consistent upward trajectory of Carlisle's net profit margin suggests effective cost management, revenue growth, or both, leading to an enhanced bottom line. Overall, the improving net profit margin reflects positively on the company's profitability performance and financial health during the period under review.


Peer comparison

Dec 31, 2023

Company name
Symbol
Net profit margin
Carlisle Companies Incorporated
CSL
16.73%
West Pharmaceutical Services Inc
WST
20.33%